Further re Shareholder Requisition Notice
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your VAL notes
ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, announces that, further to the announcement of 9 February 2024, the Company has now received legal advice regarding the validity of the requisition notice it received, which notice has been confirmed as invalid. The requisitioning shareholders have been informed and shareholders are advised to take no action at this time.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.